BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT
$6.75
-23.76%
at last close
Analyst Consensus
- Consensus Rating
- Buy (9 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $22.56
- Implied Upside
- +233.9%
- Price Target Range
- $15.00 – $29.00
- Analysts (12 mo)
- 9
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-09 | Canaccord GenuityJohn Newman |
Maintains | Buy | $23 → $20 |
| 2026-09-09 | Raymond JamesSean McCutcheon |
Maintains | Outperform | $24 → $22 |
| 2026-09-09 | StifelLaura Prendergast |
Maintains | Buy | $23 → $15 |
| 2026-09-09 | WedbushDavid Nierengarten |
Reiterates | Outperform | $25 |
| 2026-08-14 | JP MorganPriyanka Grover |
Maintains | Overweight | $27 → $25 |
| 2026-07-08 | JP MorganPriyanka Grover |
Initiates coverage on | Overweight | $27 |
| 2026-06-22 | OppenheimerMazahir Alimohamed |
Assumes | Outperform | $22 |
| 2026-05-11 | Canaccord GenuityJohn Newman |
Initiates coverage on | Buy | $23 |
| 2026-03-06 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $27 → $29 |
| 2026-02-11 | StifelLaura Prendergast |
Initiates coverage on | Buy | $23 |
| 2026-01-09 | Raymond JamesSean McCutcheon |
Initiates coverage on | Outperform | $24 |
| 2025-12-11 | WedbushDavid Nierengarten |
Reiterates | Outperform | $25 |
| 2025-12-05 | Morgan StanleySean Laaman |
Initiates coverage on | Overweight | $20 |
| 2025-11-25 | WedbushDavid Nierengarten |
Reiterates | Outperform | $25 |
| 2025-11-13 | OppenheimerMatthew Biegler |
Maintains | Outperform | $23 → $22 |
| 2025-09-17 | Leerink PartnersAndrew Berens |
Initiates coverage on | Outperform | $25 |
| 2025-09-15 | HC Wainwright & Co.Robert Burns |
Initiates coverage on | Buy | $27 |
| 2025-09-04 | OppenheimerMatthew Biegler |
Initiates coverage on | Outperform | $23 |
| 2025-08-18 | WedbushDavid Nierengarten |
Initiates coverage on | Outperform | $25 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $6.75
- Market Cap
- $710.34 million
- 52-Week Range
- $6.29 – $14.87
- Average Volume
- 301K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.